GW572016 For Treatment Of Refractory Metastatic Breast Cancer
NCT00062686
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Neoplasms, Breast
Interventions
DRUG:
GW572016
Sponsor
GlaxoSmithKline